Skip to main content
SpringerLink
Log in

Furosemide dynamics in conscious rabbits: Modulation by angiotensin II

  • Diuretics
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

The aim of this study was to investigate the effects of an infusion of angiotensin II (50 ng/kg/min) on furosemide pharmacodynamics and kinetics in the conscious rabbit. The protocol included a 90-minute phase to estimate the glomerular filtration rate and the renal plasma flow, followed by a 60-minute phase where 5 mg/kg (n=12) or 10 mg/kg (n=9) of furosemide were administered. During the pre-furosemide phase, compared to control rabbits, angiotensin II increased natriuresis and diuresis. In the presence of angiotensin II, the furosemide-induced natriuresis decreased, that is, it was 174±14 versus 95±25 µmol/min (p<0.05) and 187±17 versus 89±21 µmol/min (p<0.05) for the 5 and the 10 mg/kg doses, respectively. The infusion of angiotensin II decreased renal plasma flow without modifying the glomerular filtration rate, thus the filtration fraction was increased. Angiotensin II increased the area under the furosemide plasma concentrations as a function of time since it decreased its systemic clearance. However, furosemide urinary excretion rate was not altered and its renal clearance decreased slightly without reaching statistical significance. It is concluded that angiotensin II decreases the response to furosemide and the mechanism underlying this effect is related to the pharmacodynamics rather than the kinetics of the diuretic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Reyes AJ. Therapy with diuretics in congestive heart failure.Prog Pharmacol 1988;6:167–192.

    Google Scholar 

  2. Maharaj B. Diureties in renal failure.Prog Pharmacol 1988;6:267–288.

    Google Scholar 

  3. Imbs JL, Schmidt M, Giesen-Grouse E. Pharmacology of loop diuretics: State of the art.Adv Nephrol 1987;16:137–158.

    Google Scholar 

  4. Hammarlund-Udenaes M, Benet LZ. Furosemide pharmacokinetics and pharmacodynamics in health and disease. An update.J Pharmacokin Biopharm 1989;17:1–47.

    Google Scholar 

  5. Branch RA, Roberts CJC, Homeida M, Levine D. Determinants of response to furosemide in normal subjects.Br J Clin Pharmacol 1977;4:121–127.

    Google Scholar 

  6. Benet LZ. Pharmacokinetics/pharmacodynamics of furosemide in man: A review.J Pharmacokin Biopharm 1979;7:1–27.

    Google Scholar 

  7. Inoue M, Okajima K, Itoh K, et al. Mechanisms of furosemide resistance in analbuminemic rats and hypoalbuminemic patients.Kidney Int 1987;32:198–203.

    Google Scholar 

  8. Keller E, Hoppe-Seyler G, Mumm R, Schollmeyer P. Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.Eur J Clin Pharmacol 1981;20:27–33.

    Google Scholar 

  9. Babini R, du Souich P. Furosemide dynamics in conscious rabbits. Modulation by arginine-vasopressin.Cardiovasc Drugs Ther 1995;9:305–310.

    Google Scholar 

  10. Babini R, Larose P, Lécrivain A, du Souich P. Furosemide dynamics: Influence of dietary sodium and of saralasin.Pharmacology 1993;43:282–292.

    Google Scholar 

  11. Olsen ME, Hall JE, Montani JP, Guyton AC, Langford HG, Cornell JE. Mechanisms of angiotensin II natriuresis and antinatriuresis.Am J Physiol 1985;249:F299-F307.

    Google Scholar 

  12. Henthorn TK, Avram MJ, Frederiksen MC, Atkinsen AJ. Heterogeneity of interstitial fluid space demonstrated by simultaneous analysis of the distribution and elimination of inulin and gallamine.J Pharmacol Exp Ther 1982;222:389–394.

    Google Scholar 

  13. Early LE, Martino JA. Influence of sodium balance on the ability of diuretics to inhibit tubular reabsorption. A study of factors that influence renal tubular reabsorption in man.Circulation 1970;42:323–334.

    Google Scholar 

  14. Schreiner GE. Determination of inulin by means of resorcinol (17827).Proc Soc Exp Biol Med 1950;74:117–120.

    Google Scholar 

  15. Harvey RB, Brothers AJ. Renal extraction of para-aminohippurate and creatinine measured by in-vivo sampling of femoral and renal vein blood.Ann NY Acad Sci 1962;102:46–54.

    Google Scholar 

  16. Lambert C, Caillé G, du Souich P. Nonrenal clearance of furosemide as a cause of diuretic response variability in the rat.J Pharmacol Exp Ther 1982;222:232–236.

    Google Scholar 

  17. Larose P, Meloche S, du Souich P, de Léan A, Ong H. Radioimmunoassay of atrial natriuretic factor: Human plasma levels.Biochem Biophys Res Commun 1985;130:553–558.

    Google Scholar 

  18. Larose P, Ong H, du Souich P. Simple and rapid radioimmunoassay for the routine determination of vasopressin in plasma.Clin Biochem 1985;18:357–361.

    Google Scholar 

  19. Gibaldi M, Perrier D, eds.Pharmacokinetics, 2nd ed. New York: Marcel Dekker, 1982.

    Google Scholar 

  20. Hollenberg NK. Intrarenal and systemic actions of the renin-angiotensin system.Contrib Nephrol 1984;43:102–113.

    Google Scholar 

  21. Ribeiro AB, Kohlmann O Jr, Saragöca MA, Marson O, Ramos OL. The renin-angiotensin system in the control of systemic arterial pressure.Drugs 1985;30(Suppl 1):6–12.

    Google Scholar 

  22. Blair-West JR, Coghlan JP, Denton DA, Funder JW, Scoggins BA, Wright RD. Inhibition of renin secretion by systemic and intrarenal angiotensin infusion.Am J Physiol 1971;220:1309–1315.

    Google Scholar 

  23. Fukuchi S, Takenouchi T, Nakajima K. Effect of furosemide administration and upright position on plasma renin activity and angiotensin II in hypertension.Tohoku J Exp Med 1973;111:71–78.

    Google Scholar 

  24. Hall JE. Control of sodium excretion by angiotensin II: Intrarenal mechanisms and blood pressure regulation.Am J Physiol 1986;250:R960-R972.

    Google Scholar 

  25. Shohat J, Erman A, Boner G, Rosenfeld JB. Renal effects of angiotensin II: Role of prostaglandins.Renal Physiol 1987;10:85–92.

    Google Scholar 

  26. Navar LG, Paul RV, Carmines PK, Chou CL, Marsh DJ. Intrarenal mechanisms mediating pressure natriuresis: Role of angiotensin and prostaglandins.Fed Proc 1986;45:2885–2891.

    Google Scholar 

  27. Navar LG, Langford HG. Effects of angiotensin on the renal circulation. In: Page IH, Bumpus FN, eds.Handbook of Experimental Pharmacology, Vol 37. Berlin: Springer-Verlag, 1974:455–474.

    Google Scholar 

  28. Harris PJ, Young JA. Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney.Pflugers Arch 1977;367:295–297.

    Google Scholar 

  29. Romero JC, Knox FG. Mechanisms underlying pressurerelated natriuresis: The role of the renin-angiotensin and prostaglandin systems.Hypertension 1988;11:724–738.

    Google Scholar 

  30. Hall JE, Guyton AC, Coleman TG, Mizella HL, Woods LL. Regulation of arterial pressure: Role of pressure natriuresis and diuresis.Fed Proc 1986;45:2897–2903.

    Google Scholar 

  31. Thompson JMA, Dickinson CJ. The relation between the excretion of sodium and water and the perfusion pressure in the isolated, blood-perfused, rabbit kidney, with special reference to changes occurring in clip hypertension.Clin Sci Mol Med 1976;50:223–236.

    Google Scholar 

  32. Braam B, Mitchell KD, Fox J, Navar G. Proximal tubular secretion of angiotensin II in rats.Am J Physiol 1993;264:F891-F898.

    Google Scholar 

  33. Brater DC. Determinants to the overall response to furosemide: Pharmacokinetics and pharmacodynamics.Fed Proc 1983;42:1711–1713.

    Google Scholar 

  34. Chennavasin P, Seiwell W, Brater DC, Liang WMM. Pharmacodynamic analysis of the furosemide-probenicid interaction in man.Kidney Int 1979;16:187–195.

    Google Scholar 

  35. Vergès J, du Souich P. Extrahepatic metabolism of furosemide in the rabbit.Can J Physiol Pharmacol 1994;72(Suppl 1):299.

    Google Scholar 

  36. Smith DE, Benet LZ. Biotransformation of furosemide in kidney transplant patients.Eur J Clin Pharmacol 1983;24:787–790.

    Google Scholar 

  37. Sawhney VK, Grefory PB, Swezey SE, Blaschke TF. Furosemide disposition in ciorrhotic patients.Gastroenterology 1981;81:1012–1016.

    Google Scholar 

  38. Verbeeck RK, Patwardhan RV, Villeneuve JP, Wilkinson GR, Branch RA. Furosemide disposition in cirrhosis.Clin Pharmacol Ther 1982;31:719–725.

    Google Scholar 

  39. Verbeeck RK, Gerkens JF, Wilkinson GR, Branch RA. Disposition of furosemide in functionally hepatectomized dogs.J Pharmacol Exp Ther 1981;216:479–483.

    Google Scholar 

  40. Valentine JF, Brater DC, Krejs GJ. Clearance of furosemide by the gastrointestinal tract.J Pharmacol Exp Ther 1986;236:177–180.

    Google Scholar 

  41. Homeida N, Roberts C, Branch RA. Influence of probenicid and spironolactone on furosemide kinetics and dynamics in man.Clin Pharmacol Ther 1977;22:402–409.

    Google Scholar 

  42. Schmitt SL, Taylor K, Schmidt R, van Order D, Williamson HE. The role of volume depletion, antidiuretic hormone and angiotensin II in the furosemide-induced decrease in mesenteric conductance in the dog.J Pharmacol Exp Ther 1981;219:407–414.

    Google Scholar 

  43. Hammarlund MM, Odlind B, Paalzow LK. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.J Pharmacol Exp Ther 1985;233:447–453.

    Google Scholar 

  44. Hammarlund MM, Paalzow LK. Acute tolerance development to the diuretic effect of furosemide in the rat.Biopharm Drug Disp 1985;6:9–21.

    Google Scholar 

  45. Sjöstrom PA. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.Scand J Urol Nephrol 1988;111:1–66.

    Google Scholar 

  46. Gariépy L, Larose P, Bailey B, du Souich P. Effect of lignocaine on arginine-vasopressin plasma levels: Baseline or induced by frusemide.Br J Pharmacol 1992;106:470–475.

    Google Scholar 

  47. MacLean MR, Unger A. Effects of the renin-angiotensin on the reflex response of the adrenal medulla to hypotension in the dog.J Physiol 1986;373:343–352.

    Google Scholar 

  48. Schutz W, Hortnagl H, Magometschnigg D. Function of the autonomic nervous system in young, untreated hypertensive patients.Int J Cardiol 1986;10:133–140.

    Google Scholar 

  49. Motwani JG, Fenwick MK, Morton JJ, Struthers AD. Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure.Circulation 1992;86:439–445.

    Google Scholar 

  50. Nowack R, Fliser D, Richter J, Horne C, Mutschler E, Ritz E. Effects of angiotensin-converting enzyme inhibition on renal sodium handling after furosemide injection.Clin Pharmacol 1993;71:622–627.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de Pharmacologie, Faculté de Médecine, Université de Montréal, Succ. “Centre-ville”, C.P. 6128, H3C 3J7, Montréal, Québec, Canada

    Walid Homsy, Sylvie Marleau & Patrick du Souich M.D. Ph.D.

Authors
  1. Walid Homsy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sylvie Marleau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick du Souich M.D. Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Homsy, W., Marleau, S. & du Souich, P. Furosemide dynamics in conscious rabbits: Modulation by angiotensin II. Cardiovasc Drug Ther 9, 311–317 (1995). https://doi.org/10.1007/BF00878676

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00878676

Key Words

Search

Navigation